BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15604872)

  • 1. Topical cyclosporine A inhibits subepithelial immune infiltrates but also promotes viral shedding in experimental adenovirus models.
    Romanowski EG; Pless P; Yates KA; Gordon YJ
    Cornea; 2005 Jan; 24(1):86-91. PubMed ID: 15604872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
    Romanowski EG; Gordon YJ
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):158-62. PubMed ID: 11133861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
    Romanowski EG; Gordon YJ
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):460-3. PubMed ID: 10670476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical corticosteroids reverse the antiviral effect of topical cidofovir in the Ad5-inoculated New Zealand rabbit ocular model.
    Romanowski EG; Araullo-Cruz T; Gordon YJ
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):253-7. PubMed ID: 9019458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term treatment With a potent topical corticosteroid of an acute ocular adenoviral infection in the New Zealand white rabbit.
    Romanowski EG; Yates KA; Gordon YJ
    Cornea; 2001 Aug; 20(6):657-60. PubMed ID: 11473171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.
    Nwanegbo EC; Romanowski EG; Gordon YJ; Gambotto A
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4171-6. PubMed ID: 17724203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids Versus Cyclosporine for Subepithelial Infiltrates Secondary to Epidemic Keratoconjunctivitis: A Prospective Randomized Double-Blind Study.
    Gouider D; Khallouli A; Maalej A; Yousfi MA; Ksiaa I; Bouguerra C; Ajili F; Khairallah M
    Cornea; 2021 Jun; 40(6):726-732. PubMed ID: 33201059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Gordon YJ
    Cornea; 2002 Apr; 21(3):289-91. PubMed ID: 11917178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adenovirus type 5 early region 3 in the pathogenesis of ocular disease and cell culture infection.
    Trousdale MD; Nóbrega R; Stevenson D; Nakamura T; dos Santos PM; Labree L; McDonnell PJ
    Cornea; 1995 May; 14(3):280-9. PubMed ID: 7600812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
    Gordon YJ; Romanowski EG; Araullo-Cruz T
    Invest Ophthalmol Vis Sci; 1994 Nov; 35(12):4135-43. PubMed ID: 7960596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis.
    Okumus S; Coskun E; Tatar MG; Kaydu E; Yayuspayi R; Comez A; Erbagci I; Gurler B
    BMC Ophthalmol; 2012 Aug; 12():42. PubMed ID: 22900547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication.
    Gordon YJ; Araullo-Cruz T; Romanowski EG
    Arch Ophthalmol; 1998 Jul; 116(7):900-5. PubMed ID: 9682703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Arch Ophthalmol; 2001 Oct; 119(10):1487-91. PubMed ID: 11594949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment with 1% cyclosporine for subepithelial infiltrates secondary to adenoviral keratoconjunctivitis.
    Levinger E; Slomovic A; Sansanayudh W; Bahar I; Slomovic AR
    Cornea; 2010 Jun; 29(6):638-40. PubMed ID: 20458220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The in vitro and in vivo evaluation of ddC as a topical antiviral for ocular adenovirus infections.
    Romanowski EG; Yates KA; Gordon YJ
    Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5295-9. PubMed ID: 19516011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of corticosteroids of adenoviral replication.
    Romanowski EG; Roba LA; Wiley L; Araullo-Cruz T; Gordon YJ
    Arch Ophthalmol; 1996 May; 114(5):581-5. PubMed ID: 8619769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of adenovirus-induced eye disease in the rabbit model.
    Trousdale MD; Nóbrega R; Wood RL; Stevenson D; dos Santos PM; Klein D; McDonnell PJ
    Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2740-8. PubMed ID: 7499096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A 1% eye drops for the treatment of subepithelial infiltrates after adenoviral keratoconjunctivitis.
    Jeng BH; Holsclaw DS
    Cornea; 2011 Sep; 30(9):958-61. PubMed ID: 21673568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ganciclovir against human adenovirus type-5 infection in cell culture and cotton rat eyes.
    Trousdale MD; Goldschmidt PL; Nóbrega R
    Cornea; 1994 Sep; 13(5):435-9. PubMed ID: 7995068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
    Hillenkamp J; Reinhard T; Ross RS; Böhringer D; Cartsburg O; Roggendorf M; De Clercq E; Godehardt E; Sundmacher R
    Ophthalmology; 2002 May; 109(5):845-50. PubMed ID: 11986086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.